Blood urea nitrogen (serum or plasma) |
Initial diagnosis of acute or chronic kidney disease |
Method: Spectrophotometry |
Creatinine (serum or plasma) |
Initial diagnosis of acute or chronic kidney disease |
Method: Spectrophotometry |
Microalbumin (urine) |
May be used as a screening test |
Method: Immunoturbidimetric |
Useful in diabetic patients to assess baseline renal function |
|
Useful in monitoring diabetic nephropathy in insulin-dependent diabetes mellitus |
Creatinine based glomerular filtration rate (estimated) |
Estimate renal function and use as monitoring tool |
Method: Spectrophotometry |
(Test reports serum creatinine reference intervals) |
Cystatin-C based glomerular filtration rate (estimated) |
May be useful sensitive marker of renal disease; however, test lacks specificity due to reference range inavailability |
Method: Nephelometry |
Retinol-binding protein 4 (RBP4) |
May be used as a marker for early diabetic nephropathy. Limited studies are available |
Method: Non-commercial enzyme-linked immunosorbant assay (ELISA) |
Adiponectin |
Shown inverse correlation with renal dysfunction in type 2 diabetes |
Method: Competitive radioimmunoassay |
Connective tissue growth factor (CTGF) |
CTGF excretion is correlated inversely with GFRs |
Method: ELISA |
Alpha-1-microglobulin (urine) |
May indicate renal involvement in diabetic patients |
Method: Nephelometry |
Liver type fatty acid binding protein (L-FABP) |
Expressed in proximal tubular cells and may associated with severity of diabetic nephropathy. Larger conclusive studies are required |
Method: ELISA |